✦ LIBER ✦

Entry and evaluation of elderly patients in european organization for research and treatment of cancer (EORTC) new-drug–development studies

✍ Scribed by Silvio Monfardini; Roberto Sorio; Guido Hoctin Boes; Stan Kaye; Diego Serraino

Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 495 KB
Volume: 76
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19950715)76:2<333::aid-cncr2820760226>3.0.co;2-i

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Breast-conserving therapy for paget dise

Breast-conserving therapy for paget disease of the nipple : A prospective european organization for research and treatment of cancer study of 61 patients

✍ Nina Bijker; Emiel J.T. Rutgers; Luc Duchateau; Johannes L. Peterse; Jean-Pierre 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 2 views

A phase II study of gemcitabine in patie

A phase II study of gemcitabine in patients with malignant pleural mesothelioma

✍ Jan P. van Meerbeeck; Paul Baas; Channa Debruyne; Harry J. Groen; Chris Manegold 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## BACKGROUND. Gemcitabine has shown activity in patients with less chemosensitive solid tumors. Phase II screening of novel drugs is an accepted method with which to investigate new therapies in malignant mesothelioma. The European Organization for Research and Treatment of Cancer-Lung Cancer Coo

Prognostic value of DNA cytometry in 281

Prognostic value of DNA cytometry in 281 premenopausal patients with lymph node negative breast carcinoma randomized in a control trial : Multivariate analysis with Ki-67 index, mitotic count, and microvessel density

✍ Anne Marie Mandard; Yves Denoux; Paulette Herlin; Françoise Duigou; Marc J. van 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 2 views